Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Early improvement and response to antidepressant medications in adults with major depressive disorder. Meta-analysis and study of a sample with treatment-resistant depression
Paolo Olgiati, Alessandro Serretti, Daniel Souery, et al.
Journal of Affective Disorders (2017) Vol. 227, pp. 777-786
Closed Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

Prognosis and improved outcomes in major depression: a review
Christoph Kraus, Bashkim Kadriu, Rupert Lanzenberger, et al.
Translational Psychiatry (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 384
Results of the European Group for the Study of Resistant Depression (GSRD) — basis for further research and clinical practice
Lucie Bartova, Markus Dold, Alexander Kautzky, et al.
The World Journal of Biological Psychiatry (2019) Vol. 20, Iss. 6, pp. 427-448
Closed Access | Times Cited: 113
Prognosis and Improved Outcomes in Major Depression: A Review
Christoph Kraus, Bashkim Kadriu, Rupert Lanzenberger, et al.
FOCUS The Journal of Lifelong Learning in Psychiatry (2020) Vol. 18, Iss. 2, pp. 220-235
Open Access | Times Cited: 57
Clinical, behavioral, and neural measures of reward processing correlate with escitalopram response in depression: a Canadian Biomarker Integration Network in Depression (CAN-BIND-1) Report
Katharine Dunlop, Sakina J. Rizvi, Sidney H. Kennedy, et al.
Neuropsychopharmacology (2020) Vol. 45, Iss. 8, pp. 1390-1397
Open Access | Times Cited: 34
Duloxetine plasma level and antidepressant response
Domenico De Donatis, Vincenzo De Florio, Stefano Porcelli, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2019) Vol. 92, pp. 127-132
Closed Access | Times Cited: 28
Differences in bacterial taxa between treatment-naive patients with major depressive disorder and non-affected controls may be related to a proinflammatory profile
Julie Kristine Knudsen, Caspar Bundgaard‐Nielsen, Peter Derek Christian Leutscher, et al.
BMC Psychiatry (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Does depression with current suicidal ideation lead to treatment-resistant depression? Two large naturalistic cohorts of outpatients with depression and current suicidal ideation
Bénédicte Nobile, Elia Gourguechon-Buot, Manon Malestroit, et al.
Psychiatry Research (2024) Vol. 342, pp. 116249-116249
Open Access | Times Cited: 2
Changes in Multiple microRNA Levels with Antidepressant Treatment Are Associated with Remission and Interact with Key Pathways: A Comprehensive microRNA Analysis
Toshiya Funatsuki, Haruhiko Ogata, Hidetoshi Tahara, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 12199-12199
Open Access | Times Cited: 6
Obsessive-compulsive symptoms in major depressive disorder correlate with clinical severity and mixed features
Paolo Olgiati, Giuseppe Fanelli, Alessandro Serretti
International Clinical Psychopharmacology (2022) Vol. 37, Iss. 4, pp. 166-172
Closed Access | Times Cited: 8
Predictors of response and remission in a naturalistic inpatient sample undergoing multimodal treatment for depression
Woo Ri Chae, Johanna Nagel, Linn K. Kuehl, et al.
Journal of Affective Disorders (2019) Vol. 252, pp. 99-106
Closed Access | Times Cited: 12
Rapid response to antidepressants and correlation with response and remission after acute treatment
Fernando Fernandes, Fernando Cordeiro Pimentel, Adriana Munhoz Carneiro, et al.
Journal of Affective Disorders Reports (2024) Vol. 16, pp. 100725-100725
Open Access | Times Cited: 1
Liquid Biopsy-Based Detection and Response Prediction for Depression
Seungmin Kim, Youbin Kang, Hyunku Shin, et al.
ACS Nano (2024) Vol. 18, Iss. 47, pp. 32498-32507
Closed Access | Times Cited: 1
Allosteres to regulate neurotransmitter sulfonation
Kristie Darrah, Ting Wang, Ian Cook, et al.
Journal of Biological Chemistry (2018) Vol. 294, Iss. 7, pp. 2293-2301
Open Access | Times Cited: 12
Predictability of Nonremitting Depression After First 2 Weeks of Antidepressant Treatment: A VAST-D Trial Report
Paul B. Hicks, Varadan Sevilimedu, Gary R. Johnson, et al.
Psychiatric Research and Clinical Practice (2019) Vol. 1, Iss. 2, pp. 58-67
Open Access | Times Cited: 9
Small-molecule control of neurotransmitter sulfonation
Ian Cook, Mary Cacace, Ting Wang, et al.
Journal of Biological Chemistry (2020) Vol. 296, pp. 100094-100094
Open Access | Times Cited: 8
Combination of spontaneous regional brain activity and HTR1A/1B DNA methylation to predict early responses to antidepressant treatments in MDD
Chenjie Gao, Zhi Xu, Tingting Tan, et al.
Journal of Affective Disorders (2022) Vol. 302, pp. 249-257
Closed Access | Times Cited: 5
Venlafaxine XR treatment for older patients with major depressive disorder: decision trees for when to change treatment
Helena K. Kim, Daniel M. Blumberger, Jordan F. Karp, et al.
Evidence-Based Mental Health (2022) Vol. 25, Iss. 4, pp. 156-162
Open Access | Times Cited: 5
Predictors of Remission in Acute and Continuation Treatment of Depressive Disorders
Ha-Yeon Kim, Hee‐Joon Lee, Min Jhon, et al.
Clinical Psychopharmacology and Neuroscience (2021) Vol. 19, Iss. 3, pp. 490-497
Open Access | Times Cited: 6
Factors Affecting Antidepressant Response Trajectories: A Veterans Affairs Augmentation and Switching Treatments for Improving Depression Outcomes Trial Report
Paul B. Hicks, Varadan Sevilimedu, Gary R. Johnson, et al.
Psychiatric Research and Clinical Practice (2023) Vol. 5, Iss. 4, pp. 131-143
Open Access | Times Cited: 2
Assessment of Patients Affected by Treatment-Resistant Depression: Findings from a Real-World Study in Italy
P. Della Valentina, Diego Sangiorgi, Margherita Andretta, et al.
Journal of Psychiatry and Psychiatric Disorders (2020) Vol. 04, Iss. 03
Open Access | Times Cited: 5
Evidence-Based Assessment (EBA) in Psychiatrie, Klinischer Psychologie und Psychotherapie
Rolf‐Dieter Stieglitz, Harald J. Freyberger, Wolfgang Hiller
Zeitschrift für Psychiatrie Psychologie und Psychotherapie (2018) Vol. 66, Iss. 3, pp. 145-155
Closed Access | Times Cited: 4
Non-improvement predicts subsequent non-response to repeated-dose intravenous ketamine for depression: a re-analysis of a 2-week open-label study in patients with unipolar and bipolar depression
Chengyu Wang, Xiaofeng Lan, Weijian Liu, et al.
Translational Psychiatry (2024) Vol. 14, Iss. 1
Open Access
The Korean Medication Algorithm Project for Depressive Disorder (KMAP-DD): Changes in Preferred Treatment Strategies and Medications over 20 Years and Five Editions
Seung-Ho Jang, Won‐Myong Bahk, Young Sup Woo, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 3, pp. 1146-1146
Open Access | Times Cited: 1
Serotonin Receptors and Antidepressants: Neuroimaging Findings from Preclinical and Clinical Research
Patricia Handschuh, Melisande E. Konadu, Benjamin Spurny‐Dworak, et al.
Neuromethods (2022), pp. 373-429
Closed Access | Times Cited: 2
Concordance of the treatment patterns for major depressive disorders between the Canadian Network for Mood and Anxiety Treatments (CANMAT) algorithm and real-world practice in China
Lu Yang, Yousong Su, Sijia Dong, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top